CHASKA, Minn.--(BUSINESS WIRE)--LIFECORE BIOMEDICAL, INC. (NASDAQ:LCBM) announced today that it has entered into an exclusive license agreement and development agreement with Cleveland Clinic to develop and commercialize hyaluronan-based products and related applications.
